Correlation Between Estrella Immunopharma and USS Co

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and USS Co at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and USS Co into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and USS Co Ltd, you can compare the effects of market volatilities on Estrella Immunopharma and USS Co and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of USS Co. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and USS Co.

Diversification Opportunities for Estrella Immunopharma and USS Co

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Estrella and USS is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and USS Co Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on USS Co and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with USS Co. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of USS Co has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and USS Co go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and USS Co

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 17.46 times more return on investment than USS Co. However, Estrella Immunopharma is 17.46 times more volatile than USS Co Ltd. It trades about 0.18 of its potential returns per unit of risk. USS Co Ltd is currently generating about 0.01 per unit of risk. If you would invest  2.85  in Estrella Immunopharma on September 3, 2024 and sell it today you would earn a total of  6.25  from holding Estrella Immunopharma or generate 219.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy34.27%
ValuesDaily Returns

Estrella Immunopharma  vs.  USS Co Ltd

 Performance 
       Timeline  
Estrella Immunopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Estrella Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly fragile basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.
USS Co 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in USS Co Ltd are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong forward-looking indicators, USS Co is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Estrella Immunopharma and USS Co Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Estrella Immunopharma and USS Co

The main advantage of trading using opposite Estrella Immunopharma and USS Co positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, USS Co can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in USS Co will offset losses from the drop in USS Co's long position.
The idea behind Estrella Immunopharma and USS Co Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Directory
Find actively traded commodities issued by global exchanges